As shown in Table 2 and Figure 2(b), the median level of LAPTM4B in the healthy control group was significantly lower than in the stage I + II (p < 0.01) and III + IV BC patients (p < 0.001). The gene discussed is LAPTM4B; the disease is breast cancer.